About Us

Galapagos is a clinical-stage biotechnology company, specialised in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focussed on delivering innovative medicines that will improve people's lives.

Want to learn more about the Galapagos mission to improve the lives of patients with inflammatory diseases?
Want to find out more about Galapagos in the UK?